Phosphor study

Not Applicable

Recruiting

• Conditions: Hyperphosphatemia

• Registration Number: JPRN-jRCTs041180179
• Lead Sponsor: Shigeru Shibata

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-29
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

1)Patients in adults (over 20 years old)
2)No gender
3)Patients with eGFR (mL / min / 1.73 m 2) calculated from the serum creatinine value of 15 or more and less than 45 and serum phosphorus value of 4.0 mg / dL or more (including patients taking phosphorus adsorbent)
4)Patients whose eGFR (mL / min / 1.73 m 2) calculated from the serum creatinine value is 15 or more and less than 45 and serum phosphorus value is 4.0 mg / dL or more (patients who are taking phosphorus adsorption drugs have no acute renal function change, CKDPatients whose systemic condition is stable as treatment intervention other than administration of phosphorus adsorption is performed according to clinical guide (edited by Japan Society of Nephrology)
5)Patients receiving one or more appropriate nutritional guidance
6)Patients who agreed to participate in the study

Exclusion Criteria

1)Patients contraindicated for administration of ferric citrate hydrate
2)Patients with a history of hypersensitivity to the ingredients of this drug
3)Patients with iron overload such as hemochromatosis
4)Defective diabetes (HbA1c> 9.0%)
5)Uncontrolled hypertension (systolic blood pressure of 170 mmHg or more or diastolic blood pressure of 110 mmHg or more)
6)Acute renal failure, nephrotic syndrome, people who have undergone hemodialysis after kidney transplantation
7)tumor (no recurrence, do not exclude those who are untreated for 5 years)
8)Those who are pregnant, lactating, planning pregnancy during the study
9)Persons who are undergoing or are undergoing hormone therapy (HRT) with estrogen
10)Patient using Cinacalcet (Regala R)
11)Patients who are judged inappropriate by the attending physician (dementia, mental retardation, etc.)

Study & Design

• Study Type: Interventional
• Study Design: Not specified